1. |
Jia Li, Fei Liu, Qi Wang, et al.Genomic and transcriptomic analysis of NDM-1 Klebsiella pneumoniae in spaceflight reveal mechanisms underlying environmental adaptability. Sci Rep 2014; 4: 6216. doi:10.1038/srep06216.
|
2. |
Camargo JF, Simkins J, Beduschi T, et al.Successful treatment of Carbapenemase-producing pandrug-resistant Klebsiella pneumoniae bacteremia. Agents Chemother 2015; 59: 5903-8. doi:10.1128/AAC.00655-15.
|
3. |
Messina JA, Cober E, Richter SS, et al.Hospital readmissions in patients with carbapenem-resistant Klebsiella pneumoniae. Infect Control HospEpidemiol 2016; 37: 281-8. doi:10.1017/ice.2015.298.
|
4. |
Saidel-Odes L, Borer A.Limiting and controlling carbapenem-resistant Klebsiella pneumoniae. Infect Drug Resist 2013; 7: 9-14. doi:10.2147/IDR.S44358.
|
5. |
Liu LT, Wan LH, Song XH, et al.Relevance of class 1 integrons and extended-spectrum β-lactamases in drug- resistant Escherichia coli. Mol Med Rep 2013; 8:1251-5. doi:10.3892/mmr.2013.1626.
|
6. |
Pan YJ, Lin TL, Lin YT, et al.Identification of capsular types in carbapenem-resistant Klebsiellapneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment. Antimicrob Agents Chemother 2015; 59:1038-47. doi:10.1128/AAC.03560-14.
|
7. |
Diago-Navarro E, Chen L, Passet V, et al.Carbapenem- resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits. J Infect Dis 2014; 210: 803-13. doi:10.1093/infdis/jiu157.
|
8. |
Odumosu BT, Adeniyi BA, Chandra R.Analysis of integrons and associated gene cassettes in clinical isolates of multidrug resistant Pseudomonas aeruginosa from Southwest Nigeria. Ann Clin Microbiol Antimicrob 2013; 12: 29. doi:10.1186/1476-0711-12-29.
|
9. |
Rocha LK, dos Santos Neto RL, da Costa Guimarães AC, et al. Plasmid-mediated qnrA1 in Klebsiella pneumoniae ST147 in Recife, Brazil. Int J Infect Dis 2014; 26:49-50. doi:10.1016/j.ijid.2014.04.026.
|
10. |
Candan ED, Aksöz N.Klebsiella pneumoniae: characteristics of carbapenem resistance and virulence factors. ActaBiochim Pol 2015; 62:867-74. doi:10.18388/abp.2015_ 1148.
|
11. |
Shields RK, Clancy CJ, Hao B, et al.Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. Antimicrob Agents Chemother 2015; 59: 5793-7. doi:10.1128/AAC.00548-15.
|
12. |
Guo W, Shan K, Xu B, et al.Determining the resistance of carbapenem-resistant Klebsiella pneumoniae to common disinfectants and elucidating the underlying resistance mechanisms. Pathog Glob Health 2015; 109: 184-92. doi:10.1179/2047773215Y.0000000022.
|
13. |
Agodi A, Barchitta M, Quattrocchi A, et al.Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013. Antimicrob Resist Infect Control 2015; 4:43. doi:10.1186/s13756-015-0087-y.
|
14. |
Hosan Kim, Inder Makin, Jeff Skiba, et al.Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens. Open Microbiol J 2014; 8: 15-21. doi:10.2174/1874285801408010015.
|
15. |
Mouloudi E, Massa E, Piperidou M, et al.Tigecycline for treatment of carbapenem-resistant Klebsiella pneumonia infections after liver transplantation in the intensive care unit: a 3-year study. Transplant Proc 2014; 46:3219-21. doi:10.1016/j.transproceed.2014.09.160.
|
16. |
Lee JY, Choi MJ, Choi HJ, et al.Preservation of acquired colistinresistance in Gram-negative bacteria. Antimicrob Agents Chemother 2015; 60: 609-12. doi:10.1128/AAC.01574-15.
|
17. |
Chaari A, Mnif B, Chtara K, et al.Efficacy of tigecycline- colistin combination in the treatment of carbapenem- resistant Klebsiella pneumoniae endocarditis. J Glob Antimicrob Resist 2015;3:214-16. doi:10.1016/j.jgar.2015.06.003.
|
18. |
Yang HS, Fang WL, Lin YT.A case of liver abscess caused by tigecycline-nonsusceptible Klebsiella pneumoniae. J Microbiol Immunol Infect 2016;49:621-2. doi:10.1016/j.jmii.2016.04.010.
|
19. |
Zeighami H, Haghi F, Hajiahmadi F.Molecular characterization of integronsin clinical isolates of betalactamase producing Escherichia coli and Klebsiella pneumoniaein Iran. J Chemother 2015; 27:145-51. doi:10.1179/1973947814Y.0000000180.
|
20. |
Huang YW, Hu RM, Lin YT, et al.The contribution of class 1 integron to antimicrobial resistance in Stenotrophomonasmaltophilia. Microb Drug Resist 2015; 21:90-6. doi:10.1089/mdr.2014.0072.
|
21. |
Yuejin Z, Qingli C, Qian W, et al. Structure and function of class 1 integronin clinical isolates of Klebsiella pneumoniae. Yi Chuan 2014; 36: 603-10. Chinese. doi:10.3724/SP.J.1005.2014.0603.
|
22. |
Li B, Hu Y, Wang Q, et al.Structural diversity of class 1 integrons and their associated gene cassettes in Klebsiell- a pneumonia isolates from a hospital in China. PLoS One 2013; 8:e75805. doi:10.1371/journal.pone.0075805.
|
23. |
Liu H, Wang H, Huang M, et al.Analysis of antimicrobial resistance and class 1 integrons among strains from upper respiratory tract of healthy adults. J Thorac Dis 2013; 5:149-55. doi:10.3978/j.issn.2072-1439.2013.03.09.
|